nach oben

Erschienen in:

01.01.2016 | Original Article

Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project

verfasst von: Anamarija M. Perry, Jacques Diebold, Bharat N. Nathwani, Kenneth A. MacLennan, Hans K. Müller-Hermelink, Martin Bast, Eugene Boilesen, James O. Armitage, Dennis D. Weisenburger

Erschienen in: Annals of Hematology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Large and systematic studies of non-Hodgkin lymphoma (NHL) in the Far East (FE) with good comparative data are scarce in the literature. In this study, five expert hematopathologists classified 730 consecutive cases of newly-diagnosed NHL from four sites in the FE (excluding Japan) using the World Health Organization classification. The results were compared to 399 cases from North America (NA). We found a significantly higher male to female ratio in the FE compared to NA (1.7 versus 1.1; p < 0.05). The median ages of patients with low-grade (LG) and high-grade (HG) B-NHL in the FE (58 and 51 years, respectively) were significantly lower than in NA (64 and 68 years, respectively). The FE had a significantly lower relative frequency of B-NHL and a higher frequency of T-NHL (82 vs. 18 %) compared to NA (90.5 vs. 9.5 %). Among mature B cell lymphomas, the FE had a significantly higher relative frequency of HG B-NHL (54.8 %) and a lower frequency of LG B-NHL (27.2 %) than NA (34.3 and 56.1 %, respectively). Diffuse large B cell lymphoma was more common in the FE (49.4 %) compared to NA (29.3 %), whereas the relative frequency of follicular lymphoma was lower in the FE (9.4 %) compared to NA (33.6 %). Among T-NHL, nasal NK/T cell NHL was more frequent in the FE (5.2 %) compared to NA (0 %). Peripheral T cell lymphoma was also more common in the FE (9.1 %) than in NA (5.3 %). Further epidemiologic studies are needed to better understand the pathobiology of these differences.

Swerdlow SH, Campo E, Harris NL et al (2008) World Health Organization classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

Anderson JR, Armitage JO, Weisenburger DD (1998) Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s lymphoma classification project. Ann Oncol 9:717–720PubMedCrossRef

Laurini JA, Perry AM, Boilesen E et al (2012) Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. Blood 120:4795–4801PubMedCrossRef

Chiu BC, Hou N (2015) Epidemiology and etiology of non-Hodgkin lymphoma. Cancer Treat Res 165:1–25PubMedCrossRef

Alexander DD, Mink PJ, Adami HO et al (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1–39PubMedCrossRef

A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. (1007) Blood 89:3909-3918

Cool CD, Bitter MA (1997) The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases. Hum Pathol 28:1026–1033PubMedCrossRef

Chetty M, Sudi S, Abayomi EA (2012) Prevalence and spectrum of head and neck lymphomas at Tygerberg hospital, South Africa, 2003 to 2007. SADJ 67:270–272, 4,276-277PubMed

Castella A, Joshi S, Raaschou T, Mason N (2001) Pattern of malignant lymphoma in the United Arab Emirates—a histopathologic and immunologic study in 208 native patients. Acta Oncol 40:660–664PubMedCrossRef

10.

Almasri NM, Habashneh MA, Khalidi HS (2004) Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies. Saudi Med J 25:609–614PubMed

11.

Ameen R, Sajnani KP, Albassami A, Refaat S (2010) Frequencies of non-Hodgkin’s lymphoma subtypes in Kuwait: comparisons between different ethnic groups. Ann Hematol 89:179–184PubMedCrossRef

12.

Mozaheb Z, Aledavood A, Farzad F (2011) Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiol 35:26–29PubMedCrossRef

13.

Yaqo RT, Hughson MD, Sulayvani FK, Al-Allawi NA (2011) Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification. Indian J Cancer 48:446–451PubMedCrossRef

14.

Otrock ZK, Saab J, Aftimos G et al (2013) A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses. Pathol Oncol Res 19:715–722PubMedCrossRef

15.

Lymphoma study group of Japanese pathologists (2000) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 50:696–702CrossRef

16.

Sukpanichnant S (2004) Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol 35:224–230PubMedCrossRef

17.

Lee MY, Tan TD, Feng AC, Liu MC (2006) Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution. Am J Hematol 81:568–575PubMedCrossRef

18.

Gross SA, Zhu X, Bao L, Ryder J, Le A, Chen Y, Wang XQ, Irons RD (2008) A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol 88:165–173PubMedCrossRef

19.

Chen WL, Tsai WC, Chao TY, Sheu LF, Chou JM, Kao WY, Chen YC, Ho CL (2010) The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol 89:553–562PubMedCrossRef

20.

Yoon SO, Suh C, Lee DH, Chi HS, Park CJ, Jang SS, Shin HR, Park BH, Huh J (2010) Distribution of lymphoid neoplasms in the republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 85:760–764PubMedCrossRef

21.

Yang QP, Zhang WY, Yu JB et al (2011) Subtype distribution of lymphomas in southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6(77):1596

22.

Sun J, Yang Q, Lu Z et al (2012) Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol 138:429–434PubMedCrossRef

23.

van Leeuwen MT, Turner JJ, Joske DJ et al (2014) Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006. Int J Cancer 135:2146–2156PubMedCrossRef

24.

Jaffe ES, Harris NL, Stein H et al (2001) World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon

25.

Chang C, Huang SW, Su IJ, Chang KC (2014) Hematopathologic discrepancies between referral and review diagnoses: a gap between general pathologists and hematopathologists. Leuk Lymphoma 55:1023–1030PubMedCrossRef

26.

The World Bank database. GDP per capita. [Accessed April 16, 2015]. http://data.worldbank.org/indicator/NY.GDP.PCAP.CD

27.

China Statistical Yearbook [Accessed April 16, 2015]. http://www.stats.gov.cn/tjsj/ndsj/2014/indexeh.htm

28.

Cross AJ, Ward MH, Schenk M et al (2006) Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study. Carcinogenesis 27:293–297PubMedCrossRef

29.

Aschebrook-Kilfoy B, Ollberding NJ, Kolar C et al (2012) Meat intake and risk of non-Hodgkin lymphoma. Cancer Causes Control 23:1681–1692PubMedCrossRef

30.

Ollberding NJ, Aschebrook-Kilfoy B, Caces DB, Wright ME, Weisenburger DD, Smith SM, Chiu BC (2013) Phytanic acid and the risk of non-Hodgkin lymphoma. Carcinogenesis 34:170–175PubMedPubMedCentralCrossRef

31.

Food and Agriculture Organization of the United Nations—The State of Food and Agriculture 2009. Table A3: Per capita consumption of livestock products, 1995-2005. [Accessed March 1, 2015]. http://www.fao.org/docrep/012/i0680e/i0680e.pdf

32.

Tan HJ, Goh KL (2008) Changing epidemiology of Helicobacter pylori in Asia. J Dig Dis 9:186–189PubMedCrossRef

33.

Lim SH, Kwon JW, Kim N et al (2013) Prevalence and risk factors of helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol 13:104, 230X-13-104PubMedPubMedCentralCrossRef

34.

Anwar N, Kingma DW, Bloch AR et al (1995) The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations. Cancer 76:1245–1252PubMedCrossRef

35.

Tomita Y, Ohsawa M, Hashimoto M, Qiu K, Yang WI, Park CI, Aozasa K (1998) Plasmacytoma of the gastrointestinal tract in Korea: higher incidence than in Japan and Epstein-Barr virus association. Oncology 55:27–32PubMedCrossRef

36.

Vose J, Armitage J, Weisenburger D, International T-Cell Lymphoma Project (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124–4130PubMedCrossRef

37.

Perry AM, Molina-Kirsch H, Nathwani BN et al (2011) Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system. Leuk Lymphoma 52:1681–1688PubMedCrossRef

38.

Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–276PubMedPubMedCentralCrossRef

39.

Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS (1996) The incidence of non-Hodgkin’s lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control 7:224–230PubMedCrossRef

40.

Au WY, Gascoyne RD, Klasa RD et al (2005) Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia. Br J Haematol 128:792–796PubMedCrossRef

41.

Pan JW, Cook LS, Schwartz SM, Weis NS (2002) Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control 13:791–795PubMedCrossRef

42.

Goldman L, Ezzat S, Mokhtar N et al (2009) Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20:981–987PubMedPubMedCentralCrossRef

43.

Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Fact Sheets: Non-Hodgkin Lymphoma. [Accessed March 1, 2015]. http://seer.cancer.gov/statfacts/html/nhl.htm

Titel: Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project
verfasst von: Anamarija M. Perry
Jacques Diebold
Bharat N. Nathwani
Kenneth A. MacLennan
Hans K. Müller-Hermelink
Martin Bast
Eugene Boilesen
James O. Armitage
Dennis D. Weisenburger
Publikationsdatum: 01.01.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 2/2016
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-015-2543-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP)

Integrity of blood-brain barrier in primary CNS NK/T cell lymphoma: implications in the treatment of other primary CNS lymphomas

Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib

Cryptococcal meningoencephalitis associated with the long-term use of ruxolitinib

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin